SAN DIEGO, Dec. 7, 2022 /PRNewswire/ -- Element Biosciences, Inc.—developer of an innovative DNA sequencing platform that is disrupting the genomics industry—today announced Avidity Cloudbreak ...

“Stealth mode” barely scratches the surface of Element Biosciences’s secrecy over the past few years. More accurate would be Game of Thrones finale mode. The San Diego company’s buzz started in ...

Element Biosciences, the developer of the AVITI benchtop sequencer, will be sharing details about its technology and discussing customer stories at the annual meeting of the American Society of Human ...

SAN DIEGO and HERCULES, Calif., Feb. 8, 2023 /PRNewswire/ -- Element Biosciences, Inc. — the developer of an innovative DNA sequencing platform disrupting genomics — and Bio-Rad Laboratories, Inc.

VENLO, Netherlands, and SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Element Biosciences, Inc. today announced a strategic partnership to offer ...

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., developer of the Element AVITI™ System, a new and disruptive DNA sequencing platform, today announced it has shipped multiple AVITI systems to ...

The Element AVITI Sequencing Platform’s novel Avidity Sequencing chemistry can be easily adapted for use with the Bio-Rad SEQuoia Complete Stranded RNA Library Prep Kit and the SEQuoia Express ...

Companies unite in shared vision of enabling researchers to translate genomic insights to groundbreaking discoveries Partnership includes launch of new IDT xGen™ NGS products designed exclusively for ...

NEW YORK, June 2, 2022 /PRNewswire/ -- Gencove, pioneer of low-pass whole genome sequencing and analysis software, and Element Biosciences Inc., developer of the Element AVITI™ System, a new and ...

Partnership combines QIAGEN's QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element's AVITI System users in genomic analysis Element and QIAGEN are advancing genomic ...